Tuberculosis incidence after 36 months' isoniazid prophylaxis in HIV-infected adults in Botswana: a posttrial observational analysis. - Wikidata - awgldk - TriplyDB

Tuberculosis incidence after 36 months' isoniazid prophylaxis in HIV-infected adults in Botswana: a posttrial observational analysis.

Tuberculosis incidence after 36 months' isoniazid prophylaxis in HIV-infected adults in Botswana: a posttrial observational analysis.

http://www.wikidata.org/entity/Q37461120

about

Effect of secondary preventive therapy on recurrence of tuberculosis in HIV-infected individuals: a systematic review.The timing of tuberculosis after isoniazid preventive therapy among gold miners in South Africa: a prospective cohort study.Continuous isoniazid for the treatment of latent tuberculosis infection in people living with HIV.Pneumonia in the developing world: Characteristic features and approach to management.Benefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining tuberculosis/HIV coepidemic.HIV viral load as an independent risk factor for tuberculosis in South Africa: collaborative analysis of cohort studies.Immunological non-response and low hemoglobin levels are predictors of incident tuberculosis among HIV-infected individuals on Truvada-based therapy in Botswana.

P2860

Q30240445-41A0DF19-1694-4C22-BC8F-04210B00B068 Q36720436-51313C19-2C94-4926-AC78-60ED3FC01502 Q38686803-04FAFD1E-650F-4A8B-9BD7-BB8E037EF5AB Q38691465-2CA74986-3033-49A0-B06A-8CE2CC3163E0 Q38805328-8849AD67-ABAC-4E24-BF8C-D35A4F7D75D2 Q39002151-1AF234DF-0133-4D88-9A63-74E8DB1A6CF4 Q47547617-313BFFAC-1B7E-4485-B2FE-CA1A76147F27

P2860

Tuberculosis incidence after 36 months' isoniazid prophylaxis in HIV-infected adults in Botswana: a posttrial observational analysis.

http://www.wikidata.org/entity/Q37461120

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2015

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Tuberculosis incidence after 3 ...... ttrial observational analysis.

@en

Tuberculosis incidence after 3 ...... ttrial observational analysis.

@nl

type

label

Tuberculosis incidence after 3 ...... ttrial observational analysis.

@en

Tuberculosis incidence after 3 ...... ttrial observational analysis.

@nl

prefLabel

Tuberculosis incidence after 3 ...... ttrial observational analysis.

@en

Tuberculosis incidence after 3 ...... ttrial observational analysis.

@nl

P1433

Q37461120-4D64BB33-2EC4-434A-A816-5887E5942D25

P1476

Q37461120-1DBE1CC1-FD42-4E3F-990D-3A0C89CFC8A7

P2093

Q37461120-172D2E94-75CF-449B-9903-6E76DD6B9488

Q37461120-17AA981B-1E79-4FE0-8C56-2947E8B0756D

Q37461120-1A554861-6F43-42E0-8E27-B00B0C3A938A

Q37461120-1B1928F3-D4B8-41F8-9EFB-378F1E63A8F6

Q37461120-367CA207-735D-4401-A296-E6514438AF1B

Q37461120-36CAA970-13EB-4486-9A1D-47151D5A1AED

Q37461120-62128746-9C51-471F-8831-B38767E644C7

Q37461120-8CE7F829-7DDA-438E-A0F4-915DDA11CA6D

Q37461120-E7B1081D-DA99-4226-8BAD-DDBEDA105EEF

P2860

Q37461120-001042C9-F333-4F43-9D47-2A7C18436FA0

Q37461120-03909BA1-5FBD-4720-9E40-7AF8350D1830

Q37461120-0528BD7D-8927-4460-B1C9-BA571A1C8C41

Q37461120-0EABAF07-13B7-40F1-B90B-7A073892085B

Q37461120-0FE25684-05B5-481F-9A8D-384D93C343AC

Q37461120-3C25EAD5-B47A-485A-9ACC-B96F9D6ABAC6

Q37461120-43775C2D-CCD1-47E7-85C6-6586FDB7E751

Q37461120-446E1BF6-7A76-4ED5-BBF1-D738EB3F4960

Q37461120-5EF975FB-9DCB-4229-8EDD-9E693BBBDB17

Q37461120-696C24BE-3CF3-40CA-8F55-5DB4669358FF

P304

Q37461120-97AC969D-E5D4-4D8B-8DEB-E90EE597390D

P31

Q37461120-858055B6-C4BF-48B1-90FC-749012E105BE

P356

Q37461120-30C5EA94-C395-4B65-95EE-A8D9E2DECC78

P407

Q37461120-14001147-8A79-4015-9ECD-786EB88FA6CF

P433

Q37461120-23149314-7903-4752-8911-8750155692BE

P478

Q37461120-7F5C3A55-08B5-4BEA-94A3-3D6F0A55BC32

P50

Q37461120-7A8427E0-6903-4EA0-9AEA-C14EC6A63766

P577

Q37461120-061CEC2F-9EB3-4659-9B8A-6C5FFC86DFB2

P5875

Q37461120-F9E4A7D2-801D-45CD-ACDC-C8F252D06666

P698

Q37461120-22CFDB00-09E4-430A-B015-0636A4D1AAE2

P921

Q37461120-5BCD5371-F850-45B5-ABA7-BA5C2B53A846

Q37461120-BFC2A86D-AB66-41EE-91DF-021476E6AB17

P932

Q37461120-CD5C9AFC-F5F5-4885-BCA2-C5CCFF5DE609

P356

QAD.0000000000000535

P1433

P1476

Tuberculosis incidence after 3 ...... ttrial observational analysis.

@en

P2093

Barudi Mosimaneotsile

http://www.w3.org/2001/XMLSchema#string

Charles E Rose

http://www.w3.org/2001/XMLSchema#string

James Shepherd

http://www.w3.org/2001/XMLSchema#string

Nong Shang

http://www.w3.org/2001/XMLSchema#string

Oaitse I Motsamai

http://www.w3.org/2001/XMLSchema#string

Samba Nyirenda

http://www.w3.org/2001/XMLSchema#string

Taraz Samandari

http://www.w3.org/2001/XMLSchema#string

Tefera B Agizew

http://www.w3.org/2001/XMLSchema#string

Thabisa Sibanda

http://www.w3.org/2001/XMLSchema#string

P2860

Treatment of latent tuberculosis infection in HIV infected persons

Long-term effect of preventive therapy for tuberculosis in a cohort of HIV-infected Zambian adults.

Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa

Antiretroviral therapy and the control of HIV-associated tuberculosis. Will ART do it?

Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial

Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community.

Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis.

Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial

The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil.

Isoniazid preventive therapy, HAART and tuberculosis risk in HIV-infected adults in South Africa: a prospective cohort.

P304

351-359

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAD.0000000000000535

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

Zegabriel Tedla

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272519882

http://www.w3.org/2001/XMLSchema#string

P698

25686683

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

P932

5131631

http://www.w3.org/2001/XMLSchema#string